HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Zheng Selected Research

Proto-Oncogene Proteins c-jun

2/2001[Effects of Stat3 phosphorylation and expression of c-fos and c-jun proteins on hepatocarcinogenesis].
2/2001[Effect of activation of p-MAPK on activating c-fos and c-jun proteins in breast cancer].
2/2001Effect of phosphorylation of MAPK and Stat3 and expression of c-fos and c-jun proteins on hepatocarcinogenesis and their clinical significance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Zheng Research Topics

Disease

28Neoplasms (Cancer)
10/2021 - 02/2000
17Infections
05/2022 - 12/2000
9Alzheimer Disease (Alzheimer's Disease)
02/2015 - 02/2001
8Hepatitis B
05/2022 - 08/2016
8Breast Neoplasms (Breast Cancer)
01/2021 - 02/2000
7Hepatocellular Carcinoma (Hepatoma)
02/2018 - 04/2000
6Inflammation (Inflammations)
03/2021 - 08/2001
6Hypoxia (Hypoxemia)
09/2018 - 01/2000
5Body Weight (Weight, Body)
02/2015 - 06/2009
5Carcinogenesis
09/2014 - 02/2001
4Pain (Aches)
03/2022 - 02/2012
4Neoplasm Metastasis (Metastasis)
01/2017 - 09/2014
4Carcinoma (Carcinomatosis)
10/2014 - 12/2000
3Hemorrhage
05/2021 - 12/2012
3Pneumonia (Pneumonitis)
08/2020 - 12/2014
3Neuralgia (Stump Neuralgia)
03/2019 - 12/2011
3Reperfusion Injury
09/2018 - 07/2013
3Obesity
01/2017 - 06/2010
3Hypertension (High Blood Pressure)
07/2016 - 11/2002
3Lymphatic Metastasis
11/2013 - 12/2000
3Type 2 Diabetes Mellitus (MODY)
02/2013 - 06/2001
3Peripheral Nervous System Diseases (PNS Diseases)
12/2012 - 12/2011
3Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
09/2010 - 04/2008
3Neuroblastoma
04/2006 - 11/2000
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2006 - 10/2004
2End Stage Liver Disease
07/2022 - 03/2015
2HIV Infections (HIV Infection)
12/2021 - 01/2017
2COVID-19
08/2021 - 06/2020
2Cardiovascular Diseases (Cardiovascular Disease)
07/2021 - 01/2011
2Fibrosis (Cirrhosis)
01/2021 - 11/2000
2Wounds and Injuries (Trauma)
01/2020 - 06/2001
2Hepatitis E
04/2019 - 10/2018
2Diabetes Mellitus
12/2018 - 01/2011
2Insulin Resistance
12/2018 - 09/2009
2Hepatitis A (Hepatitis, Infectious)
10/2018 - 08/2016
2Dyspepsia (Indigestion)
01/2018 - 03/2012
2Syphilis
10/2017 - 12/2006
2Leukopenia
09/2017 - 11/2016
2Melanoma (Melanoma, Malignant)
08/2017 - 01/2017
2Rupture
07/2017 - 05/2000
2Colorectal Neoplasms (Colorectal Cancer)
01/2017 - 05/2016
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2015 - 01/2011
2Atherosclerosis
04/2015 - 02/2010
2Osteoporosis
04/2015 - 03/2000
2Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
02/2015 - 01/2013

Drug/Important Bio-Agent (IBA)

22Proteins (Proteins, Gene)FDA Link
06/2021 - 02/2000
10Pharmaceutical PreparationsIBA
06/2022 - 06/2001
9Messenger RNA (mRNA)IBA
02/2015 - 09/2000
7Hepatitis B Surface Antigens (HBsAg)FDA Link
05/2022 - 06/2013
7VaccinesIBA
09/2021 - 03/2000
7Chelating AgentsIBA
07/2013 - 06/2001
6Glucose (Dextrose)FDA LinkGeneric
12/2018 - 06/2001
6Amyloid beta-PeptidesIBA
02/2015 - 06/2001
5Paclitaxel (Taxol)FDA LinkGeneric
09/2018 - 12/2011
5PlatinumIBA
07/2014 - 12/2011
5IronIBA
04/2006 - 10/2004
4MicroRNAs (MicroRNA)IBA
02/2022 - 12/2010
4Deferoxamine (Desferal)FDA LinkGeneric
10/2017 - 01/2006
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2017 - 04/2000
4AntigensIBA
07/2017 - 06/2000
4DNA (Deoxyribonucleic Acid)IBA
01/2017 - 10/2000
4Estrogens (Estrogen)FDA Link
03/2007 - 02/2000
3Indicators and Reagents (Reagents)IBA
12/2021 - 01/2005
3taxaneIBA
01/2021 - 02/2012
3Anti-Bacterial Agents (Antibiotics)IBA
08/2020 - 08/2008
3Biological ProductsIBA
02/2018 - 01/2005
3Biomarkers (Surrogate Marker)IBA
11/2016 - 02/2011
3HDL CholesterolIBA
07/2016 - 07/2011
3Peptides (Polypeptides)IBA
02/2015 - 01/2002
3Amyloid (Amyloid Fibrils)IBA
02/2015 - 04/2006
3Oxaliplatin (Eloxatin)FDA LinkGeneric
07/2014 - 02/2012
3Monoamine Oxidase (MAO)IBA
05/2012 - 10/2004
3beta CateninIBA
07/2007 - 02/2001
3CollagenIBA
04/2001 - 01/2000
3Proto-Oncogene Proteins c-junIBA
02/2001 - 02/2001
2CreatinineIBA
07/2022 - 11/2004
2Propofol (Diprivan)FDA LinkGeneric
03/2022 - 02/2022
2Phosphotransferases (Kinase)IBA
10/2021 - 01/2017
2Hepatitis A Vaccines (Hepatitis A Vaccine)IBA
09/2021 - 08/2016
2gamma- hydroxy- gamma- ethyl- gamma- phenylbutyramide (HEPB)IBA
09/2021 - 07/2017
2ParaffinIBA
06/2021 - 12/2008
2Formaldehyde (Formol)FDA Link
06/2021 - 12/2008
2Cetuximab (Erbitux)FDA Link
03/2021 - 06/2011
2ElementsIBA
03/2019 - 01/2008
2Carrier Proteins (Binding Protein)IBA
03/2019 - 08/2016
2Bevacizumab (Avastin)FDA Link
03/2018 - 03/2014
2Sevoflurane (Ultane)FDA LinkGeneric
10/2017 - 01/2017
2Reactive Oxygen Species (Oxygen Radicals)IBA
10/2017 - 02/2015
2Caspase 3 (Caspase-3)IBA
10/2017 - 07/2007
2ChemokinesIBA
01/2017 - 08/2001

Therapy/Procedure

18Therapeutics
12/2021 - 05/2000
8Drug Therapy (Chemotherapy)
01/2021 - 12/2012
7Liver Transplantation
05/2021 - 11/2009
3Aftercare (After-Treatment)
01/2021 - 12/2000
3Transplantation
08/2020 - 07/2015
2General Anesthesia
12/2021 - 05/2018
2Stents
07/2021 - 11/2004
2Intraperitoneal Injections
03/2021 - 02/2015
2Length of Stay
08/2020 - 12/2014
2Anesthesia
06/2017 - 11/2013